1. Home
  2. APC vs EVO Comparison

APC vs EVO Comparison

Compare APC & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

APC

ARKO Petroleum Corp. Class A Common Stock

N/A

Current Price

$19.36

Market Cap

855.8M

Sector

Energy

ML Signal

N/A

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.06

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
APC
EVO
Founded
2025
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Oil Refining/Marketing
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
855.8M
934.1M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
APC
EVO
Price
$19.36
$3.06
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$21.75
$7.00
AVG Volume (30 Days)
102.0K
95.4K
Earning Date
05-11-2026
04-08-2026
Dividend Yield
10.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$4.47
$1.37
Revenue Next Year
$4.20
$10.05
P/E Ratio
$25.80
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.08
$2.31
52 Week High
$19.80
$4.80

Technical Indicators

Market Signals
Indicator
APC
EVO
Relative Strength Index (RSI) 66.61 52.19
Support Level $18.33 $2.88
Resistance Level $19.76 $3.78
Average True Range (ATR) 0.50 0.12
MACD 0.12 -0.01
Stochastic Oscillator 94.51 33.33

Price Performance

Historical Comparison
APC
EVO

About APC ARKO Petroleum Corp. Class A Common Stock

Arko Petroleum Corp is a fuel distribution company. It operates through three reportable segments: i) Wholesale: Distributes fuel to gas stations, sub-wholesalers, and bulk purchasers, typically under long-term contracts on a cost-plus or consignment basis. ii) Fleet Fueling: Operates proprietary and third-party cardlock locations serving commercial and municipal fleets, and earns commissions from proprietary fuel card sales. iii) GPMP: Supplies fuel to ARKO Retail Sites at cost plus a fixed margin, charges fixed fees to certain sites. The company generates the majority of revenue from the Wholesale segment.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: